GBR-13098

GBR-13098 is a pharmacological agent that is classified as a dopamine reuptake inhibitor. It is primarily used in scientific research to study the dopaminergic system and its effects on the body.

Pharmacology

GBR-13098 is a potent and selective inhibitor of the dopamine transporter (DAT), which is responsible for the reuptake of dopamine in the synapse. By inhibiting this transporter, GBR-13098 increases the amount of dopamine available in the synapse, which can have various effects on the body.

Uses in Research

Due to its effects on the dopaminergic system, GBR-13098 is often used in research to study conditions that are thought to involve this system, such as Parkinson's disease, schizophrenia, and drug addiction. It can also be used to study the effects of increased dopamine levels on various physiological processes, such as motor control, reward, and cognition.

Side Effects

As with any pharmacological agent, GBR-13098 can have side effects. These can include nausea, vomiting, insomnia, and anxiety. However, these side effects are generally mild and temporary.

See Also

• Dopamine reuptake inhibitor
• Dopaminergic system
• Dopamine transporter

GBR-13098 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski